<DOC>
	<DOCNO>NCT02906475</DOCNO>
	<brief_summary>The primary objective study investigate effectiveness standardize skin care regimen use milk lotion daily bath addendum need first 52 week life development atopic Dermatitis ( AD ) compare structured skin care regimen infant atopic predisposition . Secondary objective investigate influence structure skin care regimen development AD second year life skin barrier function infant ' age 2 year .</brief_summary>
	<brief_title>Atopic Dermatitis Atopy Predisposed Infants</brief_title>
	<detailed_description>Atopic dermatitis common cutaneous disease childhood . First manifestation AD usually appear early life 3rd month life often precede allergic disease asthma allergic rhinitis . AD affect 15 % child school age Germany substantial impact live life quality child family . Taking account burden health-care resource , impact quality life patient caregiver , together increase evidence AD may progress allergic phenotype , clear need improve disease prevention . Due childhood prevalence disease , prevention focus postnatal period . It recognize prevention start soon possible . Current study suggest epidermal barrier impairment important factor development AD allergic disease , gene encode filament-binding protein filaggrin ( FLG ) widely replicate significant gene influence atopic disease . Currently , standardize recommendation preventive therapy exist AD . Pilot study focus intervention enhance skin barrier function . Daily skin care emollient early birth consider reduce risk atopic dermatitis infant . The study divide 2 part : The main study ( Interventional period ) last childÂ´s age one year ( 52 week life ) follow-up period second birthday .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>1 . Written informed consent ( parent legal representative ) 2 . Healthy term newborn ( gestational age : complete 37 week ) bear mother age 1845 year 3 . Birth weight 2.500 4.500 g 4 . Age enrolment 14 day 5 . Infants enhance risk develop AD ( least one parent sibling physiciandiagnosed AD , asthma allergic rhinitis/rhino conjunctivitis report least one parent otherwise good overall health 6 . Infant Nutrition : breastfeeding cow ` smilk base infant formula ( include Hypoallergenic ( HA ) base formula ) feed combination 7 . Phototype I , II , III IV accord Fitzpatrick classification . 1 . Serious acquire congenital disease 2 . Hydrops fetalis 3 . Preterm child ( &lt; complete 37th week gestation ) 4 . Weight birth &lt; 2500 g &gt; 4500 g 5 . Significant dermatitis birth except seborrheic dermatitis scalp ( `` cradle cap '' ) 6 . Dermatological condition influence study parameter , besides benign transient neonatal disease 7 . Any immunodeficiency disorder 8 . Any severe genetic skin disorder 9 . Any serious condition would make use skin care product inadvisable 10 . Any major medical problem investigator deems may increase risk adverse event intervention assess outcome may mask underlie problem practically difficult assess 11 . Participation another clinical study 12 . Reason presume parent unable meet study plan requirement 13 . Nutrition : breastfeeding cow ` smilk base infant formula ( e.g . soybased , goatmilk base formula etc . ) 14 . History allergy intolerance investigational product 's ingredient ( ) least one subject 's parent 15 . Current topical systemic drug treatment 16 . Maternal antibiotic therapy breastfed newborns 17 . Infants mother supplement probiotic pregnancy and/or breastfeed regular basis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Dermatitis , atopic</keyword>
	<keyword>prevention control</keyword>
	<keyword>Infant</keyword>
	<keyword>Skin care</keyword>
	<keyword>randomize control trial</keyword>
</DOC>